TY - JOUR
T1 - Structure Optimization of Gatastatin for the Development of γ-Tubulin-Specific Inhibitor
AU - Shintani, Kana
AU - Ebisu, Haruna
AU - Mukaiyama, Minagi
AU - Hatanaka, Taisei
AU - Chinen, Takumi
AU - Takao, Daisuke
AU - Nagumo, Yoko
AU - Sakakura, Akira
AU - Hayakawa, Ichiro
AU - Usui, Takeo
AU - Usui, Takeo
N1 - Funding Information:
This work was supported by JSPS KAKENHI Grant Numbers JP16K07710 and JP17K01949. I.H. thanks the Okayama Foundation for Science and Technology for financial support. The authors gratefully thank the Division of Instrumental Analysis, Depaertment of Instrument Analysis & Cryogenics, Advanced Science Research Center, Okayama University, for the HR-ESIMS measurements.
Publisher Copyright:
© 2020 American Chemical Society.
PY - 2020/6/11
Y1 - 2020/6/11
N2 - Gatastatin (O7-benzyl glaziovianin A) is a γ-tubulin-specific inhibitor that is used to investigate γ-tubulin function in cells. We have previously reported that the unsubstituted phenyl ring of the O7-benzyl group in gatastatin is important for γ-tubulin inhibition. To obtain further structural information regarding γ-tubulin inhibition, we synthesized several gatastatin derivatives containing a fixed O7-benzyl moiety. Modifications of the B-ring resulted in drastic decrease in cytotoxicity, abnormal spindle formation activity, and inhibition of microtubule (MT) nucleation. In contrast, various O6-alkylated gatastatin derivatives showed potent cytotoxicity, induced abnormal spindle formation, and inhibited MT nucleation. We had previously reported that O6-benzyl glaziovianin A is a potent α/β-tubulin inhibitor; thus, these new results suggest that the O6-position restricts affinity for α/β- and γ-tubulin. Considering that an O7-benzyl group increases specificity for γ-tubulin, more potent and specific γ-tubulin inhibitors can be generated through O6-modifications of gatastatin.
AB - Gatastatin (O7-benzyl glaziovianin A) is a γ-tubulin-specific inhibitor that is used to investigate γ-tubulin function in cells. We have previously reported that the unsubstituted phenyl ring of the O7-benzyl group in gatastatin is important for γ-tubulin inhibition. To obtain further structural information regarding γ-tubulin inhibition, we synthesized several gatastatin derivatives containing a fixed O7-benzyl moiety. Modifications of the B-ring resulted in drastic decrease in cytotoxicity, abnormal spindle formation activity, and inhibition of microtubule (MT) nucleation. In contrast, various O6-alkylated gatastatin derivatives showed potent cytotoxicity, induced abnormal spindle formation, and inhibited MT nucleation. We had previously reported that O6-benzyl glaziovianin A is a potent α/β-tubulin inhibitor; thus, these new results suggest that the O6-position restricts affinity for α/β- and γ-tubulin. Considering that an O7-benzyl group increases specificity for γ-tubulin, more potent and specific γ-tubulin inhibitors can be generated through O6-modifications of gatastatin.
KW - microtubule nucleation
KW - spindle
KW - structure-activity relationships
KW - γ-Tubulin
UR - http://www.scopus.com/inward/record.url?scp=85087152705&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85087152705&partnerID=8YFLogxK
U2 - 10.1021/acsmedchemlett.9b00526
DO - 10.1021/acsmedchemlett.9b00526
M3 - Article
AN - SCOPUS:85087152705
SN - 1948-5875
VL - 11
SP - 1125
EP - 1129
JO - ACS Medicinal Chemistry Letters
JF - ACS Medicinal Chemistry Letters
IS - 6
ER -